Cargando…
Metformin and endometrial cancer survival: a quantitative synthesis of observational studies
Metformin has been reported to have anticancer effect and can affect patient survival in several malignancies. However, the results are inconclusive for endometrial cancer. Hence, we conducted a systematic review and meta-analysis to investigate the prognostic role of metformin in patients with endo...
Autores principales: | Guo, Jianfeng, Xu, Kai, An, Min, Zhao, Yingchao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630401/ https://www.ncbi.nlm.nih.gov/pubmed/29029501 http://dx.doi.org/10.18632/oncotarget.19830 |
Ejemplares similares
-
Glycosylation and its research progress in endometrial cancer
por: Pu, Congli, et al.
Publicado: (2022) -
Metformin Use Is Associated with Reduced Incidence and Improved Survival of Endometrial Cancer: A Meta-Analysis
por: Tang, Yun-Liang, et al.
Publicado: (2017) -
Therapeutic Use of Metformin in Diabetes and Survival Outcomes in Endometrial Cancer Patients with Diabetes
por: Insin, Putsarat, et al.
Publicado: (2018) -
Metformin use and survival outcomes in endometrial cancer: a systematic review and meta-analysis
por: Xie, Weimin, et al.
Publicado: (2017) -
Metformin as a Therapeutic Target in Endometrial Cancers
por: Lee, Teresa Y., et al.
Publicado: (2018)